EdgarLookup

BridgeBio Pharma, Inc. — SC 13D Filings

4 SC 13D filings on record

This page lists all SC 13D filings submitted to the SEC by BridgeBio Pharma, Inc. (BBIO), sorted by most recent first. Each row links to the full filing on EdgarLookup. BridgeBio Pharma, Inc. has filed 4 SC 13D documents with the SEC since 2018. To view all SEC filings by BridgeBio Pharma, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-Q 144 3 4 4/A 424B3 424B4 424B5 424B7 425 5 5/A 8-A12B 8-K ARS CERT CORRESP CT ORDER DEF 14A DEFA14A DEFM14A DRS DRS/A DRSLTR EFFECT PRE 14A S-1 S-1/A S-1MEF S-3ASR S-4 S-4/A S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
SC 13D SC 13D 0001193125-20-270273 Oct 15, 2020 —
SC 13D SC 13D 0001140361-19-012746 Jul 10, 2019 —
SC 13D — 0000903423-19-000277 Jul 8, 2019 —
SC 13D SC 13D 0001193125-18-233959 Aug 1, 2018 —